Aspen Pharmacare Holdings Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was ZAR 40,709 million compared to ZAR 38,606 million a year ago. Net income was ZAR 5,228 million compared to ZAR 6,488 million a year ago.

Basic earnings per share from continuing operations was ZAR 11.769 compared to ZAR 14.323 a year ago. Diluted earnings per share from continuing operations was ZAR 11.769 compared to ZAR 14.323 a year ago.